Cargando…

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration

Mesenchymal stem cells (MSCs) can be cultured relatively easily and can be obtained not only from the bone marrow, but also from medical waste such as adipose tissue and umbilical cord tissue. Because of its low antigenicity, allogeneic MSC injection is safe. MSCs have been evaluated in more than 90...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuchiya, Atsunori, Takeuchi, Suguru, Watanabe, Takayuki, Yoshida, Tomoaki, Nojiri, Shunsuke, Ogawa, Masahiro, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732839/ https://www.ncbi.nlm.nih.gov/pubmed/31516638 http://dx.doi.org/10.1186/s41232-019-0107-z

Ejemplares similares

Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
por: Terai, Shuji, et al.
Publicado: (2021)

Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions
por: Kojima, Yuichi, et al.
Publicado: (2019)

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
por: Watanabe, Takayuki, et al.
Publicado: (2020)

Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
por: Iwasawa, Takahiro, et al.
Publicado: (2021)

Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
por: Takeuchi, Suguru, et al.
Publicado: (2021)

A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
por: Nojiri, Shunsuke, et al.
Publicado: (2021)

Hypereosinophilia‐related liver pseudotumor with elevated interleukin‐5 levels preceding T‐cell lymphoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient
por: Kimura, Naruhiro, et al.
Publicado: (2020)

Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae
por: Setsu, Toru, et al.
Publicado: (2017)

Regeneration and activation of liver progenitor cells in liver cirrhosis
por: Yin, Yanze, et al.
Publicado: (2020)

Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
por: Tsuchiya, Atsunori, et al.
Publicado: (2017)

Prognostic study of acute-on-chronic liver failure patients: Usefulness of the fibrosis-4 index
por: Watanabe, Yusuke, et al.
Publicado: (2022)

Small extracellular vesicles and liver diseases: From diagnosis to therapy
por: Tsuchiya, Atsunori, et al.
Publicado: (2022)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
por: Watanabe, Yusuke, et al.
Publicado: (2021)

Liver stem cells: Plasticity of the liver epithelium
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model
por: Ikarashi, Shunzo, et al.
Publicado: (2019)

Analysis of distribution, collection, and confirmation of capacity dependency of small extracellular vesicles toward a therapy for liver cirrhosis
por: Takeda, Nobutaka, et al.
Publicado: (2023)

Screening and follow‐up of chronic liver diseases with understanding their etiology in clinics and hospitals
por: Ogawa, Masahiro, et al.
Publicado: (2020)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2022)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Autonomic nervous system network and liver regeneration
por: Kamimura, Kenya, et al.
Publicado: (2018)

The Role of MSCs and Cell Fusion in Tissue Regeneration
por: Dörnen, Jessica, et al.
Publicado: (2021)

Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis
por: Sakaida, Isao, et al.
Publicado: (2016)

Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis
por: Natsui, Kazuki, et al.
Publicado: (2020)

Changes in Magnetic Resonance Imaging Findings in a Malignant Melanoma Patient
por: Setsu, Toru, et al.
Publicado: (2020)

A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow–derived cells
por: Matsuda, Takashi, et al.
Publicado: (2017)

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
por: Yoshiji, Hitoshi, et al.
Publicado: (2021)

Variation in small bowel transit time on capsule endoscopy
por: Tominaga, Kentaro, et al.
Publicado: (2020)

Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Rational arrangement of measuring shear wave speed in the liver
por: Yokoo, Takeshi, et al.
Publicado: (2019)

Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography
por: Takeda, Nobutaka, et al.
Publicado: (2021)

Iliopsoas Muscle Hematoma Secondary to Alcoholic Liver Cirrhosis
por: Yamashita, Suguru, et al.
Publicado: (2012)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7927io2nkl0deg5i7rcn4l3t4d